+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Biomarkers: Global Strategic Business Report

  • PDF Icon

    Report

  • 272 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 834989

Global Cardiac Biomarkers Market to Reach $28 Billion by 2030

The global market for Cardiac Biomarkers estimated at US$15.7 Billion in the year 2022, is projected to reach a revised size of US$28 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2022-2030. Troponins (T & I), one of the segments analyzed in the report, is projected to record a 8.7% CAGR and reach US$11.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Brain Natriuretic Peptide (BNPs) or NT-proBNP segment is readjusted to a revised 7.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.3 Billion, While China is Forecast to Grow at 12.2% CAGR

The Cardiac Biomarkers market in the U.S. is estimated at US$4.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.6 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 7.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.9 Billion by the year 2030.

Select Competitors (Total 39 Featured) -

  • Abbott Diagnostics
  • Beckman Coulter Inc.
  • BG Medicine
  • bioMérieux SA
  • Boditech Med Inc.
  • Labsystems Diagnostics OY
  • LifeSign LLC
  • LSI Medience Corp.
  • Merck KGaA
  • Ortho-Clinical Diagnostics Inc.
  • Quidel Corporation
  • Randox Laboratories
  • Response Biomedical Corp.
  • Roche Diagnostics Corp.
  • Siemens Healthineers

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • A Curtain Raiser
  • Major Cardiac Markers and their Properties
  • Recent Market Activity
  • Market Set to Record Strong Growth Led by Advancements in Cardiac Biomarker Combinations
  • North America Corners Biggest Slice, Asia-Pacific to Dictate Market Momentum
  • Laboratory Testing Remains Gold Standard, POC Testing Rapidly Gains Traction
  • Analysis by Type of Cardiac Biomarker Assay/Test
  • Competitive Landscape
  • Intense Competition among Players in the Cardiac Diagnostics Market
  • Leading Vendors Focus on Curtailing Turnaround Time of POC Cardiac Testing Kits
  • Cardiac Markers Point-Of-Care Testing (POC) Cardiac Testing Segment: Major Players and their Operating Brands
  • Other Recent Innovations
  • Lipid Biomarker Panel to Detect HfrEF
  • VectraplexECG System with CEB® Cardiac Electrical Biomarker
  • Cardiac Biomarkers on Smartphone
  • Stringent Regulations and Other Challenges
  • Cardiac Biomarkers - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • Abbott Diagnostics, Inc. (USA)
  • Quidel Corporation (USA)
  • Beckman Coulter, Inc. (USA)
  • BG Medicine, Inc. (USA)
  • biomérieux SA (France)
  • Boditech Med Inc. (South Korea)
  • Labsystems Diagnostics OY (Finland)
  • LifeSign LLC (USA)
  • LSI Medience Corporation (Japan)
  • Ortho-Clinical Diagnostics, Inc. (USA)
  • Randox Laboratories Ltd. (UK)
  • Response Biomedical Corp. (Canada)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (USA)
  • Merck KGaA (Germany)
3. MARKET TRENDS & DRIVERS
  • The Grim Reality of Mounting Economic and Social Burden of Cardiovascular Disease
  • Population Explosion, Ballooning Geriatric Populace, Longer Life Expectancy Contributing to Rising Tide of CVDs
  • Cardiac Biomarkers Hold the Key to Timely, Accurate Diagnosis & Prognosis
  • Commercialization of Novel Biomarkers to Drive Market Growth
  • Personalized Medicine, Companion Diagnostics Open Up Opportunities for Cardiac Biomarker Developers
  • Cardiac Biomarkers - A Powerful Tool for Patient Triaging
  • Cardiac Biomarkers Market Transitions from Mono-Marker to Multi-Marker Assays
  • Government Support Instrumental for Boosting Market Momentum
  • Secretoneurin Biomarker - a Potential Game Changer for Diagnosis of Cardiac Arrhythmias
  • High-Performance Techniques Drive Biomarker Discovery in Cardiology
  • Biomarkers for Acute Coronary Syndromes (ACS): A Leading Segment
  • Biomarkers - A Promising Diagnostic Tool for ACS
  • Biomarker Discovery for ACS to Undergo Significant Changes
  • Cardiac Biomarker Play Critical Role in Stroke Diagnosis
  • Cardiac Biomarkers to Find a Place in Neonatal Diagnosis and Treatment
  • Specificity, Sensitivity, Side Effects, Cost Concerns Hinder Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Laboratory Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Point-of-Care Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Point-of-Care Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Point-of-Care Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Troponins (T & I) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Troponins (T & I) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Troponins (T & I) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Brain Natriuretic Peptide (BNPs) or NT-proBNP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Brain Natriuretic Peptide (BNPs) or NT-proBNP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Brain Natriuretic Peptide (BNPs) or NT-proBNP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Myocardial Muscle Creatine Kinase (CK-MB) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Myocardial Muscle Creatine Kinase (CK-MB) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Myocardial Muscle Creatine Kinase (CK-MB) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Myoglobin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Ischemia-Modified Albumin (IMA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Ischemia-Modified Albumin (IMA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Ischemia-Modified Albumin (IMA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 26: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 27: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 28: World Cardiac Biomarkers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Diagnostics
  • Beckman Coulter Inc.
  • BG Medicine
  • bioMérieux SA
  • Boditech Med Inc.
  • Labsystems Diagnostics OY
  • LifeSign LLC
  • LSI Medience Corp.
  • Merck KGaA
  • Ortho-Clinical Diagnostics Inc.
  • Quidel Corporation
  • Randox Laboratories
  • Response Biomedical Corp.
  • Roche Diagnostics Corp.
  • Siemens Healthineers

Table Information